Details of Drug

Drug General Information (ID: D0783)
Drug Name	Ibandronate
Drug Type	Small molecule
Drug Synonymous	BFQ; Acid ibandronico; Ibandronic Acid; Bisphosphonate 2; R484; RPR 102289A; Bondronat (TN); Boniva (TN); Bonviva (TN); Ibandronic acid (INN); Ibandronic acid [INN:BAN]; RPR-102289A; Ibandronic acid, sodium salt, monohydrate; Roche brand of ibandronic acid, sodium salt, monohydrate; [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid; [1-HYDROXY-3-(METHYL-PENTYL-AMINO)-1-PHOSPHONO-PROPYL]-PHOSPHONIC ACID; (1-Hydroxy-3-(methylpentylamino)propylidene)diphosphonic acid; (1-hydroxy-3-(methylpentylamino)propylidene)bisphosphonate; 1-hydroxy-3-(methylpentylamino)propylidenebisphosphonate Click to Show/Hide
Disease Class	FB83: Low bone mass disorder
Therapeutic Class	Bone Density Conservation Agents
Structure
Structure	3D Structure		2D Structure
Formula	C9H23NO7P2
InChI	1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17)
InChIKey	MPBVHIBUJCELCL-UHFFFAOYSA-N
Canonical SMILES	CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
External Link
	Pubchem ID	60852
	CAS Number	114084-78-5
	TTD ID	D08SJZ

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects BM003 Complex formation BM027 Decreased renal excretion due to nephrotoxicity BM054 Increased risk of GI mucosal injury/bleeding risk BM063 Increased risk of hypocalcemia BM072 Increased risk of nephrotoxicity BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Ibandronate
Affected gastrointestinal absorption
	Complex formation					Drug Num: 28
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0235		Calcium acetate	C4H6CaO4	6116	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0125		Attapulgite	Al2H29Mg2O15Si4-	56842194	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0236		Calcium carbonate	CCaO3	10112	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0238		Calcium citrate	C12H10Ca3O14	13136	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0239		Calcium glubionate anhydrous	C18H32CaO19	64776	Moderate		Inter Info	[37], [31], [39]
D0243		Calcium lactate	C6H10CaO6	13144	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0244		Calcium Phosphate	Ca3O8P2	24456	Moderate		Inter Info	[37], [31], [39]
D0332		Chromium picolinate	C18H12CrN3O6	151932	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0390		Copper gluconate	C12H22CuO14	10692	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0649		Ferrous fumarate	C4H2FeO4	6433164	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0650		Ferrous gluconate	C12H22FeO14	23616740	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0651		Ferrous sulfate anhydrous	FeO4S	24393	Moderate		Inter Info	[37], [31], [39]
D0847		Iron	Fe	23925	Moderate		Inter Info	[37], [31], [39]
D0850		Iron sucrose	C12H29Fe5Na2O23	91663255	Moderate		Inter Info	[36], [37], [31]
D0877		Kaolin	Al2H4O9Si2	56841936	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0968		Magnesium carbonate	CMgO3	11029	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0969		Magnesium chloride	Cl2H12MgO6	643991	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0971		Magnesium gluconate	C12H22MgO14	11418570	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0972		Magnesium glycinate	C4H8MgN2O4	84645	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0974		Magnesium oxide	MgO	14792	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D1456		Selenium	Se	6326970	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D1566		Tetraferric tricitrate decahydrate	C18H32Fe4O31	90478690	Moderate		Inter Info	[37], [31], [39]
D1724		Zinc gluconate	C12H22O14Zn	443445	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D1725		Zinc sulfate	O4SZn	24424	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D0975		Magnesium sulfate	MgO4S	24083	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
D1511		Sucralfate	C12H54Al9O55S8	121494085	Moderate		Inter Info	[35], [36], [37], [31], [38], [39]
Affected excretion pathways
	Decreased renal excretion due to nephrotoxicity					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0668		Flucytosine	C4H4FN3O	3366	Moderate		Inter Info	[46]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[33], [14], [47], [48], [49]
D1543		Telbivudine	C10H14N2O5	159269	Moderate		Inter Info	[51]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[52]
Pharmacodynamic additive effects
	Increased risk of GI mucosal injury/bleeding risk					Drug Num: 19
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0432		Deferasirox	C21H15N3O4	214348	Major		Inter Info	[12], [13]
D0298		Celecoxib	C17H14F3N3O2S	2662	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0645		Fenoprofen	C15H14O3	3342	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0210		Bromfenac	C15H12BrNO3	60726	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0331		Choline salicylate	C12H19NO4	54686350	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0624		Etodolac	C17H21NO3	3308	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0680		Flurbiprofen	C15H13FO2	3394	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0786		Ibuprofen	C13H18O2	3672	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0881		Ketoprofen	C16H14O3	3825	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0988		Meclofenamic acid	C14H11Cl2NO2	4037	Moderate		Inter Info	[36], [37], [42]
D0991		Mefenamic acid	C15H15NO2	4044	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D1109		Naproxen	C14H14O3	156391	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D1272		Phenyl salicylate	C13H10O3	8361	Moderate		Inter Info	[36], [37], [42]
D1439		Salicylic acid (sodium)	C7H6O3	338	Moderate		Inter Info	[36], [37], [42]
D1442		Salsalate	C14H10O5	5161	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0800		Indomethacin	C19H16ClNO4	3715	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D0882		Ketorolac	C15H13NO3	3826	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D1097		Nabumetone	C15H16O2	4409	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
D1520		Sulindac	C20H17FO3S	1548887	Moderate		Inter Info	[14], [40], [41], [36], [30], [37], [31], [42], [43], [38], [28]
	Increased risk of hypocalcemia					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0615		Etelcalcetide	C38H73N21O10S2	71511839	Major		Inter Info	[14]
D0056		Amikacin	C22H43N5O13	37768	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]
D0704		Furosemide	C12H11ClN2O5S	3440	Moderate		Inter Info	[28]
D0217		Bumetanide	C17H20N2O5S	2471	Moderate		Inter Info	[28]
D1120		Neomycin	C23H46N6O13	8378	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]
D1126		Netilmicin	C21H41N5O7	441306	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]
D1507		Streptomycin	C21H39N7O12	19649	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]
	Increased risk of nephrotoxicity					Drug Num: 37
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0335		Cidofovir	C8H14N3O6P	60613	Major		Inter Info	[1]
D0472		Diatrizoate	C11H9I3N2O4	2140	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D0765		Human immunoglobulin G (intravenous)	NA	NA	Major		Inter Info	[9], [10], [11]
D0761		Human botulinum neurotoxin A/B immune globulin	NA	NA	Major		Inter Info	[9], [10], [11]
D0763		Human cytomegalovirus immune globulin	NA	NA	Major		Inter Info	[9], [10], [11]
D0768		Human Rho(D) immune globulin	NA	NA	Major		Inter Info	[9], [10], [11]
D0805		Inotersen	C230H318N69O121P19S19	121492004	Major		Inter Info	[14], [15]
D0831		Iodipamide	C20H14I6N2O6	3739	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D0832		Iodixanol	C35H44I6N6O15	3724	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D0833		Iohexol	C19H26I3N3O9	3730	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D0834		Iopamidol	C17H22I3N3O8	65492	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D0836		Iopromide	C18H24I3N3O8	3736	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D0837		Iothalamic acid	C11H9I3N2O4	3737	Major		Inter Info	[4], [5], [6]
D0838		Ioversol	C18H24I3N3O9	3741	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D0839		Ioxilan	C18H24I3N3O8	3743	Major		Inter Info	[2], [3], [4], [5], [6], [7], [8]
D1476		Sirolimus	C51H79NO13	5284616	Major		Inter Info	[16], [17], [18]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[16], [17], [18]
D0075		Amphotericin B	C47H73NO17	5280965	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D0076		Amphotericin B (cholesteryl sulfate)	C47H73NO17	5280965	Moderate		Inter Info	[32], [22], [28]
D0078		Amphotericin B (liposomal)	C47H73NO17	5280965	Moderate		Inter Info	[32], [22], [28]
D0142		Bacitracin	C66H103N17O16S	10909430	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D0252		Capreomycin	C50H88N28O15	3000502	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D0344		Cisplatin	Cl2H6N2Pt	5702198	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[44]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D0383		Colistimethate	C58H105N16O28S5-5	70789202	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D0709		Gallium nitrate	GaN3O9	61635	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D0829		Iobenguane (I-131)	C8H10IN3	60860	Moderate		Inter Info	[32], [22], [28]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[32], [22], [28]
D1091		Moxetumomab Pasudotox	NA	NA	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D1173		Olsalazine	C14H10N2O6	22419	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D1310		Polymyxin B	C56H98N16O13	49800004	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D1517		Sulfasalazine	C18H14N4O5S	5339	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D1549		Temsirolimus	C56H87NO16	6918289	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
D1680		Vancomycin	C66H75Cl2N9O24	14969	Moderate		Inter Info	[19], [20], [21], [22], [23], [24], [25], [30], [31], [27], [28], [29]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0177		Bevacizumab	NA	NA	Moderate		Inter Info	[33], [14], [34]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[14], [45]
D1426		Romosozumab	NA	NA	Moderate		Inter Info	[50]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[33], [14], [34]

References
1	Product Information. Vistide (cidofovir). Gilead Sciences, Foster City, CA.
2	Wong GT, Lee EY, Irwin MG. Contrast induced nephropathy in vascular surgery.?Br J Anaesth. 2016;117 Suppl 2:ii63-ii73. [PMID: 27566809]
3	Bennett WM, Porter GA "Nephrotoxicity of common drugs used by urologists." Urol Clin North Am 17 (1990): 145-56. [PMID: 2407013]
4	Bentley ML, Corwin HL, Dasta J "Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies." Crit Care Med 38(6 Suppl) (2010): S169-74. [PMID: 20502171]
5	Dubrovskaya Y, Prasad N, Lee Y, Esaian D, Figueroa DA, Tam VH "Risk factors for nephrotoxicity onset associated with polymyxin B therapy." J Antimicrob Chemother 70 (2015): 1903-7. [PMID: 25652747]
6	Kellum JA, Leblanc M, Venkataraman R "Acute renal failure." BMJ Clin Evid 9 (2008): 2001. [PMID: 19445797]
7	Marcos LA, Camins BC, Ritchie DJ, Casabar E, Warren DK "Acute renal insufficiency during telavancin therapy in clinical practice." J Antimicrob Chemother 67 (2012): 723-6. [PMID: 22174040]
8	van den Berk G, Tonino S, de Fijter C, Smit W, Schultz MJ "Bench-to-bedside review: Preventative measures for contrast-induced nephropathy in critically ill patients." Crit Care 9 (2005): 361-70. [PMID: 16137385]
9	Guo X, Nzerue C "How to prevent, recognize, and treat drug-induced nephrotoxicity.".
10	Centers for Disease Control and Prevention (CDC). Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.?MMWR Morb Mortal Wkly Rep. 1999;48(24):518-521. [PMID: 10401909]
11	Product Information. BabyBIG (botulism immune globulin). FFF Enterprises, Temecula, CA.
12	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
13	Rafat C, Fakhouri F, Ribeil JA, Delarue R, Le Quintrec M "Fanconi Syndrome Due to Deferasirox." Am J Kidney Dis (2009):. [PMID: 19493602]
14	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
15	Product Information. Tegsedi (inotersen). Akcea Therapeutics, Cambridge, MA.
16	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
17	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
18	Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM "Acute renal, failure associated with the use of ibuprofen in two liver transplant recipients on FK506." Transplantation 57 (1994): 1132-3. [PMID: 7513099]
19	Banerjee D, Asif A, Striker L, Preston RA, Bourgoignie JJ, Roth D "Short-term, high-dose pamidronate-induced acute tubular necrosis: The postulated mechanisms of bisphosphonate nephrotoxicity." Am J Kidney Dis 41 (2003): E18. [PMID: 12778436]
20	Chang JT, Green L, Beitz J "Renal failure with the use of zoledronic acid." N Engl J Med 349 (2003): 1676-9 discussion 1676-9. [PMID: 14573746]
21	Janssen Van Doorn K, Neyns B, Van Der Niepen P, Verbeelen D "Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases." Nephron 89 (2001): 467-8. [PMID: 11721169]
22	Kanis JA, Preston CJ, Yates AJ, Percival RC, Mundy KI, Russell RG "Effects of intravenous diphosphonates on renal function." Lancet 1 (1983): 1328. [PMID: 6134112]
23	Lockridge L, Papac RJ, Perazella MA "Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis." Am J Kidney Dis 40 (2002): E2. [PMID: 12087588]
24	Markowitz GS, Fine PL, Stack JI, et al. "Toxic acute tubular necrosis following treatment with zoledronate (Zometa)." Kidney Int 64 (2003): 281-289. [PMID: 12787420]
25	Osullivan TL, Akbari A, Cadnapaphornchai P "Acute renal failure associated with the administration of parenteral etidronate." Ren Fail 16 (1994): 767-73. [PMID: 7899588]
26	Pedersen-Bjergaard U, Myhre J "Severe hypocalcaemia [corrected] after treatment with diphosphonate and aminoglycoside." Br Med J 302 (1991): 295. [PMID: 1825614]
27	Product Information. Ostac (clodronate). Hoffmann-La Roche Limited, Mississauga, IA.
28	Product Information. Zometa (zoledronic acid). Novartis Pharmaceuticals, East Hanover, NJ.
29	Zazgornik J, Grafinger P, Biesenbach G, Hubmann R, Fridrik M "Acute renal failure and alendronate." Nephrol Dial Transplant 12 (1997): 2797-8. [PMID: 9430905]
30	Product Information. Aredia (pamidronate). Novartis Pharmaceuticals, East Hanover, NJ.
31	Product Information. Boniva (ibandronate). Roche Laboratories, Nutley, NJ.
32	Chang JT, Green L, Beitz J "Renal failure with the use of zoledronic acid." N Engl J Med 349 (2003): 1676-9 discussion 1676-9. [PMID: 14573746]
33	Cerner Multum, Inc. "Australian Product Information.".
34	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
35	Darcy PF "Nutrient-drug interactions." Adverse Drug React Toxicol Rev 14 (1995): 233-54. [PMID: 8845456]
36	Product Information. Actonel (risedronate). Procter and Gamble Pharmaceuticals, Cincinnati, OH.
37	Product Information. Bonefos (clodronate). Rhone-Poulenc Rorer Canada Inc, Laval, QC.
38	Product Information. Fosamax (alendronate). Merck & Co, Inc, West Point, PA.
39	Product Information. Skelid (tilundronate). Sanofi Winthrop Pharmaceuticals, New York, NY.
40	Graham DY, Malaty HM "Alendronate and naproxen are synergistic for development of gastric ulcers." Arch Intern Med 161 (2001): 107-10. [PMID: 11146706]
41	Graham, Malaty "Alendronate and naproxen are synergistic for development of gastric ulcers (Vol 161, pg 107, 1921)." Arch Intern Med 161 (2001): 1862. [PMID: 11146706]
42	Product Information. Didronel I.V. Infusion (etidronate). MGI Pharma Inc, Minnetonka, MN.
43	Product Information. Didronel Tablets (etidronate). Procter and Gamble Pharmaceuticals, Cincinnati, OH.
44	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
45	Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
46	Product Information. Ancobon (flucytosine). Roche Laboratories, Nutley, NJ.
47	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
48	Gilead Sciences, Inc "About Remdesivir.".
49	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
50	Product Information. Evenity (romosozumab). Amgen USA, Thousand Oaks, CA.
51	Product Information. Tyzeka (telbivudine). IDEC Pharmaceuticals Corporation, San Diego, CA.
52	Product Information. Eloxatin (oxaliplatin). Sanofi Winthrop Pharmaceuticals, New York, NY.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence